cheshtasharma

About Cheshta Sharma

This author has not yet filled in any details.
So far Cheshta Sharma has created 1323 blog entries.

Copyright Infringement case against Delhi University

Copyrights are legal protection given to a creator for a specific period of time to exploit his own creation. Copyrights include literary, artistic and musical work. The importance of copyright is to promote the creation of new works by giving authors control of and profit from them. Copyrights are said to be territorial, which means [...]

By |2017-09-07T13:41:58+05:30October 22nd, 2012|Copyright|0 Comments

APPLE’S DESIGN: NOT INFRINGED BY SAMSUNG

The patent war between two giants which are Apple and Samsung isn’t new. They have been fighting like Tom and Jerry, just to show the world who is stronger with respect to intellectual property. Many lawsuits have been filed by one on the other and by other on the first one. This patent par [...]

By |2017-08-30T19:00:33+05:30October 20th, 2012|IP Basics, Patent|0 Comments

CONTROLLER GENERAL’S DECISION ON OCI

In a recent judgment given on 25th September, 2012 Karnataka high court quashed Controller’s General order of banning a person with ‘Overseas Citizenship of India’ from practicing as a patent agent. The court also gave the Controller General, liberty to conduct a new inquiry and determine if he should be in Register of Patent Agent [...]

By |2017-09-07T13:40:05+05:30October 20th, 2012|IP Basics, Patent|0 Comments

ANDA leading to Patent Infringement

Johnson & Johnson (J&J) is an American multinational medical devices, pharmaceutical and consumer packaged goods manufacturer founded in 1886. J&J filed for a patent on 9th June, 1999 which was granted to them on 10th April, 2001. The patent was US6214815 titled, “Triphasic oral contraceptive”. Lupin Pharmaceuticals Inc. a subsidiary of Lupin Limited works [...]

By |2017-09-07T13:39:19+05:30October 20th, 2012|Patent|0 Comments

PATENTS EXPIRE, INDIAN GENERICS GAIN

In next three year, patents of many multinational companies are going to expire. This will open a vast market for Indian generic companies. Indian generic companies are eyeing to capture an estimated $40 billion worth of market for generic or copied medicines. The main focus of the companies is on the countries with ageing [...]

By |2017-09-09T11:56:25+05:30October 20th, 2012|Patent|0 Comments
Go to Top